Pretreatment Anti-Thyroid Autoantibodies Indicate Increased Risk for Thyroid Autoimmunity Secondary to Alemtuzumab: A Prospective Cohort Study
EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2019.07.062
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Elsevier BV